ACTION Trial- Adoptive Cellular Therapy Following Dose-Intensified Temozolomide in Newly-Diagnosed Pediatric High-Grade Gliomas (Phase I)

Grant

Total Award Amount

  • 56254.00
  • Direct Costs

  • 43272.00
  • Sponsor Award Id

  • Contributor

  • Elizabeth Alva   Investigator  
  • Girish Dhall   Principal Investigator  
  • Gregory Friedman M.D.   Investigator  
  • Hilary Haines   Investigator  
  • Laura Metrock   Investigator  
  • Mina Lobbous   Investigator